Advertisement

Topics

Cormedix, Inc.: CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update

16:20 EDT 9 Aug 2017 | FinanzNachrichten

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time Recent Corporate and Clinical Highlights: Implemented several key FDA-agreed changes to the LOCK-IT-100 trial designed to enhance event...

Original Article: Cormedix, Inc.: CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update

NEXT ARTICLE

More From BioPortfolio on "Cormedix, Inc.: CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...